Descubre y comparte nuestro conocimiento público

World Health Organization ,  [The strategic use of antiretrovirals for treatment and prevention of HIV infection: report of a WHO technical consultation, 14-16 November 2011, Geneva, Switzerland]

World Health Organization ,  [Technical update on treatment optimization: use of efavirenz during pregnancy: a public health perspective : June 2012, Actualización técnica sobre la optimización del tratamiento : uso de efavirenz durante el embarazo : una perspectiva de salud pública : Junio del 2012]

World Health Organization ,  United States. National Institutes of Health, Department of Health and Human Services ,  [Meeting report: WHO – NIH Informal Consultation on Antiretroviral Treatment as HIV Prevention: Implementation Science in Asia. 26-28 March 2012, Siem Reap, Cambodia: executive summary.]

Всемирная организация здравоохранения ,  [Быстрый совет: Использование антиретровирусных препаратов для лечения беременных женщин и профилактики ВИЧ-инфекции у младенцев: рекомендации 2009 г.]

World Health Organization ,  [Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS, Sources et prix d'une sélection de médicaments et tests diagnostiques pour les personnes vivant avec VIH/SIDAFuentes y precios de medicamentos y diagnósticos seleccionados para personas viviendo con VIH/SIDA]

World Health Organization ,  [Values and preferences – maternal and child health summary, Consultation for the development of the WHO Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection]

World Health Organization ,  [Discussion forum on option B+ with civil society leaders]

World Health Organization ,  [Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access : recommendations for a public health approach, Médicaments antirétroviraux pour traiter la femme enceinte et prévenir l' infection à VIH chez l' enfant : vers un accès universel : recommandations basées sur une approche de santé publique, 2006 version]

World Health Organization ,  [Transaction prices for antiretroviral medicines from 2009 to 2012 : WHO AIDS medicines and diagnostics services, global price reporting mechanism : summary report November 2012]

World Health Organization ,  Suthar, A B ,  Lawn, S D ,  del Amo, J ,  Getahun, H ,  Dye, C ,  Sculier, D ,  Sterling, T R ,  Chaisson, R E ,  Williams, B G ,  Harries, A D ,  Granich, R M ,  [Should early antiretroviral therapy (CD4 > 350 cells/mm3) vs deferred antiretroviral therapy (CD4 < 350 cells/mm3) be used for prevention of tuberculosis?]